tefinostat (CHR-2845) / Chroma Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tefinostat (CHR-2845) / Chroma Therap
CHR-2845, NCT02759601 / 2012-000326-22: Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)

Unknown status
1/2
69
Europe
Tefinostat
Queen Mary University of London, Chroma Therapeutics
Hepatocellular Carcinoma
12/18
12/18

Download Options